Mumbai, July 28 (PTI): Cipla Ltd has posted a 10.83 per cent rise in net profit at Rs 67.2 crore for the first quarter ended June 30 compared with Rs 60.63 crore in the same period of the previous year.
Total income for the period was Rs 460.91 crore as against Rs 407.73 crore reported in the year-ago period.
The board has also declared a dividend of Rs 10 per equity share for the last financial year.
GlaxoSmithKline Pharma-ceuticals Ltd has posted a 59.7 per cent rise in net profit at Rs 64.76 crore for the second quarter ended June 30 compared with Rs 40.55 crore in the same period of the previous fiscal.
Net sales increased to Rs 324.92 crore as against Rs 306.25 crore in the second quarter of the last fiscal.
Other income was also higher at Rs 8.66 crore (Rs 8.51 crore in the year-ago period).
For the first half ended June 30, the company has posted a net profit of Rs 99.85 crore (Rs 63.57 crore) and net sales rose to Rs 607.78 crore (Rs 591.82 crore).
Burroughs fares well
Burroughs Wellcome (India) Ltd has reported a 41.64 per cent rise in net profit at Rs 16.02 crore for the second quarter ended June 30 compared with Rs 11.31 crore posted in the same period of the previous fiscal.
Net sales in the second quarter has increased to Rs 58.64 crore as against Rs 50.33 crore in same period of last year.
For the six months ended June 30, net profit was up at Rs 24.02 crore (Rs 16.19 crore in the year-ago period) while net sales were higher at Rs 102.39 crore (Rs 89.34 crore).
BSES powers ahead
BSES Ltd today reported a 11 per cent rise in net profit for the quarter ended June 30 at Rs 88.2 crore compared with Rs 79.19 crore during the same period previous fiscal and approved the merger of BSES Andhra Power Ltd with itself.
Total income during the quarter grew 14 per cent to Rs 804.04 crore as against Rs 704.87 crore.
The merger of BAPL will increase the asset base of BSES by Rs 650 crore and turnover by Rs 250 crore.